Anacor Pharmaceuticals, Inc. 4
4 · Anacor Pharmaceuticals, Inc. · Filed Jun 3, 2016
Insider Transaction Report
Form 4
Bell Graeme
Executive VP and CFO
Transactions
- Sale
Common Stock
2016-06-01$99.28/sh−751$74,559→ 10,255 total
Footnotes (1)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.